デフォルト表紙
市場調査レポート
商品コード
1225280

前立腺がん治療市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測

Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
前立腺がん治療市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前立腺がん治療市場規模は、2022年に72億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に5.8%の成長率(CAGR)を示し、2028年までに103億米ドルに達すると予想しています。

前立腺がんは、男性に存在する前立腺の様々な異常細胞の制御不能な分裂と拡大によって引き起こされる重篤な悪性腫瘍の一種です。ワクチン、薬物療法、治療法などの様々な治療法の使用により治療することができます。中でも、化学療法、免疫療法、凍結療法、手術療法、ホルモン療法、標的療法、放射線療法は、体内のがん細胞の広がりを抑制する最も一般的な治療法の一つです。これらの治療法は、患者の年齢、経験した症状の重さ、病状、過去の健康歴など、さまざまな評価に基づいて患者に提供されます。

前立腺がん治療薬の市場動向

  • 前立腺がんの有病率、特に老年人口が増加していることは、現在、市場を成長へと導く主要な要因の一つです。これに伴い、有利な医療費償還政策や、患者支援プログラム(PAP)導入に向けた各国の政府機関別数々の取り組みも、成長を促進する要因となっています。PAPは、製薬会社によって管理され、治療目的のために薬を無料で提供することで、患者に経済的支援を提供する組織的なプログラムです。さらに、非転移性去勢抵抗性(nmCRPC)および転移性ホルモンネイブ(mHNPC)設定によるマルチパラメトリック磁気共鳴画像(mp-MRI)装置の統合など、診断エラーを軽減しながら早期段階で前立腺がんを検出するための著しい技術的進歩も市場成長に寄与しています。さらに、新しい治療製品を導入するための研究開発活動への大規模な投資と、さまざまなオンラインおよびオフラインの流通チャネルでの容易な入手が、市場に明るい展望を生み出しています。

主な市場セグメンテーション

  • IMARC Groupは、世界の前立腺がん治療市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供しています。当レポートでは、薬剤の種類と販売チャネルに基づいて市場を分類しています。

薬剤タイプ別の内訳

  • 化学療法
  • 生物学的療法
  • ホルモン療法
  • その他

販売チャネル別内訳

  • 病院薬局
  • ドラッグストア・小売店
  • オンライン薬局

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東・アフリカ地域

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 前立腺がん治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 薬剤タイプ別市場内訳

  • 化学療法
    • 市場動向
    • 市場予測
  • 生物学的製剤
    • 市場動向
    • 市場予測
  • ホルモン療法
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 流通チャネル別市場内訳

  • 病院薬局
    • 市場動向
    • 市場予測
  • ドラッグストア・薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場展望

第8章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC.(Sanpower Group Co. Ltd.)
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • GlaxoSmithKline Plc
    • Ipsen(Mayroy SA)
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
図表

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2022
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players
目次
Product Code: SR1423A121_Report

The global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

  • The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global prostate cancer treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.
  • Key Questions Answered in This Report
  • 1. What was the size of the global prostate cancer treatment market in 2022?
  • 2. What is the expected growth rate of the global prostate cancer treatment market during 2023-2028?
  • 3. What are the key factors driving the global prostate cancer treatment market?
  • 4. What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5. What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7. What are the key regions in the global prostate cancer treatment market?
  • 8. Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio